"Alternative" endocytic mechanisms exploited by pathogens: new avenues for therapeutic delivery?
about
Non-Viral Nucleic Acid Delivery Strategies to the Central Nervous SystemCellular Endocytosis and Trafficking of Cholera Toxin B-Modified Mesoporous Silica NanoparticlesThe utilization of pathogen-like cellular trafficking by single chain block copolymerPathologic prion protein infects cells by lipid-raft dependent macropinocytosisThe emergence of multiple particle tracking in intracellular trafficking of nanomedicines.A preliminary study on the interaction between Asn-Gly-Arg (NGR)-modified multifunctional nanoparticles and vascular epithelial cellsNon-degradative intracellular trafficking of highly compacted polymeric DNA nanoparticlesNTS-Polyplex: a potential nanocarrier for neurotrophic therapy of Parkinson's diseaseAcute and chronic shear stress differently regulate endothelial internalization of nanocarriers targeted to platelet-endothelial cell adhesion molecule-1.Action and reaction: the biological response to siRNA and its delivery vehicles.Cellular uptake of nanoparticles: journey inside the cell.Lipid-based nanocarriers for breast cancer treatment - comprehensive review.Autonomous translocation and intracellular trafficking of the cell-penetrating and immune-suppressive effector protein YopM.Intracellular trafficking pathways involved in the gene transfer of nano-structured calcium phosphate-DNA particlesDifferential intra-endothelial delivery of polymer nanocarriers targeted to distinct PECAM-1 epitopes.Internalization of the Active Subunit of the Aggregatibacter actinomycetemcomitans Cytolethal Distending Toxin Is Dependent upon Cellugyrin (Synaptogyrin 2), a Host Cell Non-Neuronal Paralog of the Synaptic Vesicle Protein, Synaptogyrin 1.Determining the relationship between nanoparticle characteristics and immunotoxicity: key challenges and approaches.
P2860
Q28068242-3B2FBCA9-844C-48B5-BA38-5C116C562AD3Q28834075-9DB15F4A-AAA0-422D-8BB1-25E35F28EB7EQ30499330-D1D044FD-1924-4EF2-B0AB-4318B7579855Q33434501-DBAD54D0-AC3E-409D-9FB2-24BDED3E5396Q33639580-B5FD10C3-5C89-461B-920D-4435603DA442Q33682897-CE14DFBC-AB6F-4A40-A5DF-AAAFFD881C60Q35803649-A1F6EFCD-E767-4DB2-AD2F-C89E1442DFA9Q36089698-989F0D0D-A95F-41E1-8FFB-CD3AEF0F6921Q37416891-9B4D63F2-3891-40B3-ABC6-5D154465A29CQ37976576-B2E676C2-C6C2-4EA7-AAE5-A78C30093667Q38557482-6F2E6A72-5183-47F6-B18A-5F1E5F3D77F8Q38597794-1BD892AB-E0AF-4805-A7D1-BC8ECD49612EQ41395684-B8F354FE-5E31-4E76-AA79-7F5FD1E08256Q42054391-EBE0C6C6-CA23-4CDB-8DD0-FD0D5C9F5518Q43210433-12DE18F6-24F7-4F97-A803-AFD186FADCB6Q47116717-5CB09370-3D00-4081-93CD-CA936ECC391CQ53755427-4AA675D2-4C68-49DA-891E-BE693EECAB06
P2860
"Alternative" endocytic mechanisms exploited by pathogens: new avenues for therapeutic delivery?
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
"Alternative" endocytic mechan ...... nues for therapeutic delivery?
@en
type
label
"Alternative" endocytic mechan ...... nues for therapeutic delivery?
@en
prefLabel
"Alternative" endocytic mechan ...... nues for therapeutic delivery?
@en
P2860
P1476
"Alternative" endocytic mechan ...... nues for therapeutic delivery?
@en
P2093
L K Medina-Kauwe
P2860
P304
P356
10.1016/J.ADDR.2007.06.009
P407
P577
2007-07-05T00:00:00Z